Healthcare
Medical Developments International Limited(MDDVF)
Live Price
Offline$0.37
+0.00% today
1Y Change
-27.11%
Window
Jun 25, 2025 → Jun 18, 2026
- Market Cap
- $50.00M
- Revenue Growth
- +17.8%
- EPS Growth
- +100.2%
- Dividend Yield
- 0.0%
Coverage: 253 bars · Jun 25, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Medical Developments International Limited (MDDVF) is a Healthcare stock with a market cap of $50.00M and listed on OTC. The stock last traded around $0.37 and down 27.1% across the available one-year price window (Jun 25, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +17.8%, EPS growth of +100.2%, a dividend yield of 0.0%. What stands out right now is revenue +17.8%, EPS +100.2%, free cash flow +96.5% with operating margin 0.8% and ROIC 0.6%. Valuation is more restrained than many high-expectation growth names at price/sales 1.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines MDDVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+17.8% vs +7.6% peer median
Operating Margin
Below sector median
+0.8% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +17.8% and EPS at +100.2%, with operating margin around 0.8%.
Benchmark Edge
MDDVF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MDDVF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MDDVF Max Drawdown
-40.15%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MDDVF and SPY.
Company Overview
Medical Developments International Limited
Other OTC
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
- Leadership
- Brent MacGregor
- IPO Date
- Jan 21, 2020
- Employees
- 68
- Street Address
- 4 Caribbean Drive
- Mailing
- Scoresby, VIC, 3179
- Region
- Scoresby, VIC, AU
- Reporting Currency
- USD
- Investor Line
- 61 3 9547 1888
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- 131.1
- Price/Sales
- 1.3
- Price/Book
- 1.0
Growth
- Revenue
- +17.8%
- EPS
- +100.2%
- Free Cash Flow
- +96.5%
Profitability
- Gross Margin
- 52.7%
- Operating Margin
- 0.8%
- Net Margin
- -1.1%
- ROE
- -0.8%
- ROIC
- 0.6%
Balance Sheet
- Debt/Equity
- 0.06
- Current Ratio
- 6.07
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.